Microbes as biomarkers and targets in pancreatic cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Microbiome-pancreatic cancer crosstalk: From tumor biology to therapeutic intervention.iMetaOmics · 2026
   Review
2. Fecal profiling reveals a common microbial signature for pancreatic cancer in Finnish and Iranian cohorts.Gut pathogens · 2025
   Article
3. Correlation between gut microbiota and tumor immune microenvironment: A bibliometric and visualized study.World journal of clinical oncology · 2025
   Article
4. Getting off tract: contributions of intraorgan microbiota to cancer in extraintestinal organs.Gut · 2023
   Review
5. The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment.Cancers · 2023
   Review
6. Applying multi-omics toward tumor microbiome research.iMeta · 2023
   Review
7. Bibliometric analysis of global research trends between gut microbiota and pancreatic cancer: from 2004 to 2023.Frontiers in microbiology · 2023
   Review
8. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool.Biomolecules · 2022
   Review
9. Species-resolved sequencing of low-biomass or degraded microbiomes using 2bRAD-M.Genome biology · 2022
   Article
10. Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine.Indian journal of surgical oncology · 2021
    Review
11. The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer.Frontiers in oncology · 2021
    Article
12. Intratumoral levels and prognostic significance ofAging · 2020
    Article
13. Integrating the Tumor Microenvironment into Cancer Therapy.Cancers · 2020
    Review

Corrections and comments

• Comment on
  Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.2019

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as